IMPAKT Study: Imaging Modalities in Pediatric Assessments of Kidney Transplants
IMPAKT 研究:儿科肾移植评估中的成像方式
基本信息
- 批准号:10662566
- 负责人:
- 金额:$ 17.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdultAdvisory CommitteesAllograftingBackBiological MarkersBiopsyBlood VesselsBlood capillariesBlood flowChildChildhoodChildhood InjuryChronicChronic Kidney FailureClinicalClinical ResearchContrast MediaDataData AnalysesDeteriorationDevelopment PlansDiagnosisDialysis procedureDiffusionDoctor of PhilosophyEarly DiagnosisEnd stage renal failureEnsureEnvironmentExtravasationFailureFistulaFoundationsFreedomFunctional disorderFutureGlomerular Filtration RateGoalsHealthHemorrhageHypoxiaImageImage EnhancementImaging technologyImmunologicsImmunotherapyIndividualInfiltrationInflammationInflammatoryInjuryInterventionInvestigationKidney DiseasesKidney TransplantationLeadershipLongevityMagnetic Resonance ImagingMeasuresMentorsMentorshipMicrobubblesNephrologyNon-Invasive DetectionOncogenicOperative Surgical ProceduresOutcomeParticipantPatternPediatric HospitalsPennsylvaniaPerfusionPhiladelphiaPositioning AttributeProcessPrognosisPrognostic MarkerPublic HealthRenal functionResearchResearch DesignResearch PersonnelResearch Project GrantsResearch TrainingRiskScientistStatistical MethodsStructureTimeTrainingTranslational ResearchTransplant RecipientsTransplantationUltrasonographyUniversitiesallograft rejectionarterial spin labelingbiomedical imagingcareercareer developmentcohortcontrast enhancedcostdata acquisitiondesigndiagnosis standarddiagnostic biomarkerexperiencefollow-upgraft failureimaging biomarkerimaging modalityimprovedindexingkidney allograftmortalitymultidisciplinarynon-invasive imagingnoninvasive diagnosisnovelpatient orientedpatient oriented researchpersonalized managementpersonalized medicinepost-transplantpre-clinicalquantitative imagingrate of changeresearch studyskillssuccesssurveillance imagingtooltreatment planningultrasoundvasoconstrictionwater diffusion
项目摘要
PROJECT SUMMARY/ ABSTRACT
The overarching objectives of this proposal are to investigate whether novel quantitative MRI and ultrasound
imaging parameters can reliably detect kidney transplant injury that indicates risk of allograft failure in children.
Children with end-stage kidney disease (ESKD) have a mortality rate 30 times higher than children without it. As
kidney transplantation provides a significant survival advantage over dialysis, children with ESKD often require
multiple kidney allografts over their lifespan. Each transplant increases surgical, immunological, and oncogenic
risk. Kidney allograft injury results from inflammatory, infectious, vascular, and fibrotic changes that can
ultimately result in allograft failure. A major limitation to promoting long-term allograft survival is the lack of non-
invasive diagnostic and prognostic biomarkers to reliably detect early injury in the allograft. This proposal seeks
to develop magnetic resonance imaging (MRI) and contrast-enhanced ultrasound (CEUS) biomarkers to
measure inflammation of kidney transplant in children. Currently, kidney allograft biopsy is the gold standard to
diagnose such changes, but is invasive and not free of complications, which limits its use. Identifying such
markers will allow us to implement individualized interventions to improve allograft survival and decrease
unnecessary biopsies. Aim 1 will determine advanced MRI and CEUS parameters that associate with
histopathological total inflammation Banff score and Chronic Allograft Damage Index (CADI) score. Aim 2 will
identify novel MRI and CEUS parameters that predict change of eGFR in pediatric kidney transplant recipients
at 6-24 months post-transplantation. The results will inform the field of novel non-invasive imaging biomarkers
in pediatric kidney transplantation. Complementary to this investigation I plan to acquire further training in 1)
conventional and CEUS research imaging acquisition and analysis, 2) MRI research data acquisition and
analysis, 3) design and implementation of biomedical imaging based patient-oriented research studies, and 4)
acquire leadership skills through a professional development plan in the rigorous research environment of
Children’s Hospital of Philadelphia and University of Pennsylvania. To accomplish these goals, I have assembled
a multi-disciplinary mentoring/advisory team of experts in clinical nephrology patient-oriented research (Primary
mentor, Susan Furth, MD, PhD), MRI clinical and translational research studies (Timothy Roberts, MD, PhD;
Suraj Serai, PhD), CEUS (Chandra Seghal, PhD; Susan Back, MD; Anush Sridharan, PhD), pediatric kidney
transplantation biomarkers (Sandra Amaral, MD, MHS), multinational collaborative networks (Gregory Tasian,
MD, MSCE), kidney disease statistical methods (Jarcy Zee, PhD), and patient-oriented imaging research (Kassa
Darge, MD, PhD; Erum Hartung, MD, MSTR; Hansel Otero, MD). The proposed research, along with the
structured mentoring, coursework, and training that comprise my career development plan, will provide me with
the skills and experience necessary to ensure my success as an independent investigator with a unique skill set
in developing imaging biomarkers for kidney transplantation.
项目摘要/摘要
该提案的总体目标是研究新颖的定量MRI和超声是否
成像参数可以可靠地检测到肾移植损伤,这表明儿童同种异体移植失败的风险。
末期肾脏疾病(ESKD)的儿童的死亡率是没有该儿童的儿童的30倍。作为
肾脏移植提供了比透析具有显着的生存优势,ESKD的儿童通常需要
在其寿命中多个肾脏同类。每次移植都会增加手术,免疫学和致癌性
风险。肾脏同种异体移植损伤是由炎症,传染性,血管和纤维化变化引起的,可以
最终导致同种异体移植失败。促进长期同种异体移植存活的主要局限性是缺乏非 -
侵入性诊断和预后生物标志物可靠地检测出同种异体移植物的早期损伤。该建议寻求
开发磁共振成像(MRI)和对比增强超声(CEU)生物标志物
测量儿童肾脏移植的炎症。目前,肾脏同种异体移植活检是
诊断出这种变化,但具有侵入性,并且不含并发症,这限制了其使用。确定这样的
标记将使我们能够实施个性化的干预措施,以改善同种异体移植生存并减少
不必要的活检。 AIM 1将确定与之相关的高级MRI和CEU参数
组织病理学总炎症班夫评分和慢性同种异体移植损伤指数(CADI)得分。 AIM 2意志
确定可预测小儿肾脏移植受者EGFR的变化的新型MRI和CEU参数
移植后6-24个月。结果将为新型非侵入性成像生物标志物的领域提供信息
在小儿肾脏移植中。补充这项投资,我计划在1中获得进一步的培训
常规和CEU研究成像获取和分析,2)MRI研究数据获取和
分析,3)基于生物医学成像的研究和实施,以患者为导向的研究,4)
通过专业发展计划在严格的研究环境中获得领导技能
费城儿童医院和宾夕法尼亚大学。为了实现这些目标,我已经组装了
临床肾脏科专家的多学科心理/咨询团队患者研究(主要
心理,医学博士Susan Fuurth),MRI临床和翻译研究(Timothy Roberts,MD,PhD;
Suraj Serai,博士),CEUS(Chandra Seghal,PhD; Susan Back,医学博士; Anush Sridharan,PhD),儿科肾脏
移植生物标志物(Sandra Amaral,MD,MHS),跨国协作网络(Gregory Tasian,Gregory Tasian,
MD,MSCE),肾脏疾病统计方法(Jarcy Zee,PhD)和面向患者的成像研究(KASSA)
Darge,医学博士;医学博士Erum Hartung; Hansel Otero,MD)。拟议的研究,以及
结构化的心理,课程和培训完成了我的职业发展计划,将为我提供
确保我作为独立技能的独立调查员成功所需的技能和经验
在开发用于肾脏移植的成像生物标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bernarda Viteri Baquerizo其他文献
Bernarda Viteri Baquerizo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bernarda Viteri Baquerizo', 18)}}的其他基金
IMPAKT Study: Imaging Modalities in Pediatric Assessments of Kidney Transplants
IMPAKT 研究:儿科肾移植评估中的成像方式
- 批准号:
10524906 - 财政年份:2022
- 资助金额:
$ 17.93万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Early life stress impacts molecular and network properties that bias the recruitment of pro-stress BLA circuits
早期生活压力会影响分子和网络特性,从而影响促压力 BLA 回路的募集
- 批准号:
10820820 - 财政年份:2023
- 资助金额:
$ 17.93万 - 项目类别:
Temporospatial Single-Cell Characterization of Angiogenesis and Myocardial Regeneration in Small and Large Mammals
小型和大型哺乳动物血管生成和心肌再生的时空单细胞表征
- 批准号:
10751870 - 财政年份:2023
- 资助金额:
$ 17.93万 - 项目类别:
Bacteriophage as a predictive biomarker in chronic Pseudomonas airway disease
噬菌体作为慢性假单胞菌气道疾病的预测生物标志物
- 批准号:
10723956 - 财政年份:2023
- 资助金额:
$ 17.93万 - 项目类别:
Function and Targeting of ETV6 in Ewing Sarcoma
ETV6 在尤文肉瘤中的功能和靶向
- 批准号:
10740562 - 财政年份:2023
- 资助金额:
$ 17.93万 - 项目类别:
Bispecific Antibody Maintenance Therapy after Allogeneic Bone Marrow Transplant
同种异体骨髓移植后的双特异性抗体维持治疗
- 批准号:
10572777 - 财政年份:2023
- 资助金额:
$ 17.93万 - 项目类别: